Chenlin Hu, PhD

University of Houston
Houston, Texas, United States

Disclosure(s): No financial relationships to disclose

Presentation(s):

• 435 - Evaluation of Fecal Pharmacokinetics and Metagenomic Changes Following the Administration of Intravenous Omadacycline to Healthy Subjects

  Friday, October 18, 2024
  4:15 PM – 4:27 PM US PT